Miko et al. demonstrated that lithocholic acid (LCA), a secondary bile acid produced exclusively by bacteria, inhibits epithelial-mesenchymal transition (EMT) and vascular endothelial growth factor A (VEGFA) expression and boosts antitumor immunity in a breast cancer cell line23. Here, VEGFA is linked to breast cancer.